Coegin Pharma
3.65 SEK
+0.83 %
Less than 1K followers
COEGIN
Nordic SME
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+0.83 %
-15.70 %
-17.79 %
-34.82 %
+24.57 %
-12.26 %
-69.41 %
-90.78 %
-88.53 %
Coegin Pharma is a Swedish biotechnology company in commercial phase, developing science-based innovations for hair and skin. The company's patented ingredient for hair growth is now available in products sold through selected partners. A peptide for natural skin pigmentation is also in development with a planned launch in the near future. Coegin Pharma is headquartered in Lund.
Read moreMarket cap
104.36M SEK
Turnover
286.02K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26/2
2026
Annual report '25
21/5
2026
Interim report Q1'26
21/5
2026
General meeting '26
All
Press releases
ShowingAll content types
Coegin Pharma provides an operational and strategic update
Coegin Pharma appoints worldleading pigmentation and hair-biology expert Professor Desmond J. Tobin as Scientific Advisor
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools